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ABSTRACT
In a rare occasion a single chromosomal locus was
targeted twice by independent Alu-related retro-
poson insertions, and in both cases supported
neuronal expression of the respective inserted
genes encoding small non-protein coding RNAs
(npcRNAs): BC200 RNA in anthropoid primates and
G22 RNA in the Lorisoidea branch of prosimians. To
avoid primate experimentation, we generated trans-
genic mice to study neuronal expression and protein
binding partners for BC200 and G22 npcRNAs. The
BC200 gene, with sufficient upstream flanking seq-
uences, is expressed in transgenic mouse brain
areas comparable to those in human brain, and G22
gene, with upstream flanks, has a similar expression
pattern. However, when all upstream regions of the
G22 gene were removed, expression was completely
abolished, despite the presence of intact internal
RNA polymerase III promoter elements. Transgenic
BC200 RNA is transported into neuronal dendrites
as it is in human brain. G22 RNA, almost twice
as large as BC200 RNA, has a similar subcellu-
lar localization. Both transgenically expressed
npcRNAs formed RNP complexes with poly(A)
binding protein and the heterodimer SRP9/14, as
does BC200 RNA in human. These observations
strongly support the possibility that the indepen-
dently exapted npcRNAs have similar functions,
perhaps in translational regulation of dendritic
protein biosynthesis in neurons of the respective
primates.
INTRODUCTION
Even after discovering that RNA itself has catalytic activity
(1,2) the doctrine remained: the few surviving functional
RNAs, including ribosomal RNAs, tRNAs and others are fos-
silized remnants of the long gone RNA/RNP worlds. Recent
developments forced us to rethink. Experimental and compu-
tational RNomics uncovered a plethora of non-protein coding
RNAs (npcRNAs) [reviewed in (3,4)]. The discovery of non-
protein coding RNAs that arose relatively recently in diverse
metazoan lineages, such as BC1 RNA in rodents (5), sphinx
RNA in Drosophila melanogaster (6), the bsr transcript (7)
that harbors RBII-36 snoRNA in the Rattus genus (8),
BC200 RNA in anthropoid primates (9), and G22 RNA in
the Lorisoidea branch of prosimians (10) indicates that func-
tional non-protein coding RNAs are not merely fossils from
the RNA and RNP worlds. Retroposition is much more per-
vasive in the evolution of genes (protein coding and other)
and genomes. Continued recruitment (or exaptation) of
novel RNA molecules including snoRNAs and miRNAs
into cellular processes underscores the signiﬁcance of study-
ing biogenesis of npcRNAs and their cellular functions, such
studies will aid in establishing molecular causes of physiolo-
gical differences of species (11–14). The timing of biogenesis
of BC1 and BC200 npcRNAs is well documented. BC1 RNA
arose by retroposition of a tRNA
Ala after the mammalian
radiation in rodents. BC1 RNA is prevalently expressed in
neurons and transported to dendritic processes (15). Targeted
deletion of its gene reduces exploratory behavior and
increases anxiety of mice (16,17). BC200 RNA (200 nt in
length) arose independently by retroposition of a monomeric
Alu element into a locus that permitted expression in primate
neurons. It has been shown to be dendritic in human brain (9).
Interestingly, both RNAs despite their different evolutionary
origins might have analogous functions (18). BC1 and BC200
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doi:10.1093/nar/gkl1082RNAs inhibit translation in vitro as well as in transfected
cells. At lower concentrations, however, Alu RNAs appear
to stimulate translation (19). Consequently, the BC RNAs
have been suggested to regulate translation in dendritic micro-
domains (19–22). Such a role is supported by identiﬁcation
of protein partners that play roles in translation including
SRP9/14 for BC200 RNA (23,24) and PABP for both BC1
and BC200 RNAs as well as for transcribed SINEs with
poly(A) tails (18,20,25). When the BC RNAs are preincubated
with PABP prior to the in vitro translation assay, the inhibitory
effect is less pronounced (20). Hence other possible functions
for BC1 and BC200 RNAs have to be entertained (20).
Previously, we demonstrated that the ancestrally unoccu-
pied G22/BC200 RNA locus was independently targeted by
two different but related SINE elements, once in strepsir-
rhines and once in anthropoid primates (10). Thus, G22
RNA, derived from a dimeric Alu element, inserted into the
same locus as BC200 RNA at a different time in a different
primate lineage (10). Moreover, it has been shown for Lorisi-
formes and Anthropoidea that both insertions are transcrip-
tionally active and mainly brain-speciﬁc. Based on HeLa
cell transfection experiments, it was proposed that the
BC200/G22 locus harbors promoter elements required for
maintaining the tissue-speciﬁc transcription of both genes
(10). As studying functional aspects of these molecules in pri-
mates is hampered by a number of ethical or conservational
restrictions, we generated transgenic mice that simulate
expression of BC200 and G22 npcRNAs in the original
primate species. Here we report studies on their transcrip-
tional regulation, cellular and subcellular location as well as
their interaction with protein partners.
MATERIALS AND METHODS
BC200 and Gmo22 transgenic mice
The 3.2 kb EcoRI–HindIII DNA fragment for BC200
( 2271) transgenic mice was released from the l bacterioph-
age BC200-9a, with the respective restriction enzymes (26)
(Figure 1D). DNA fragments for the production of BC200
( 515) and BC200 ( 250) transgenic mice were PCR amp-
liﬁed from l bacteriophage BC200-9a (26) (Figure 1D). The
following pairs of oligonucleotides were used for PCR
ampliﬁcation: BC200 ( 515): BC2TR2dir 50-TTGAGACC-
TTGAGGGGCTTTT-30 and BC2TR4rev 50-CTTCCAGGC-
AAGAATATGAAAAG-30; BC200 ( 250): BC2TR4dir 50-AT-
TTAAATTCAGAGCCAAAAG-30 and BC2TR2rev 50-TACTG
ATTAAAAAAGTAAAAAG-30. PCR fragments were cloned
into the pBluescript vector and sequenced. DNA fragments
for Gmo ( 383) and Gmo (+1) transgenic mice were
obtained from the plasmids pGmo—( 383) and pGmo—
(+1), respectively (10) (Figure 1D). All DNA fragments
were released by respective restriction endonucleases and
puriﬁed through agarose gel electrophoresis.
For transgenic mice production, DNAs were diluted up to
the concentration of 2 mg/ml and injected into the pronuclei
Figure 1. Northern blot analysis of RNA from BC200 and Gmo22 transgenic mice. Northern blot hybridization of total RNA isolated from various tissues of
BC200 ( 2271)—(A); BC200 ( 515), BC200 ( 250)—(B); Gmo22 ( 383) and Gmo22 (+1)—(C) transgenic mice as indicated in the figures was performed.
Hybridization was carried with
32P-labeled oligonucleotide probes: BC207–BC200 RNA-specific (A and B) and G22-30-specific probe for G22 RNA (C). As a
loading control, all blots were hybridized with
32P-labeled 7SL_30 oligonucleotide—specific probe for 7SL RNA. Respective RNAs are indicated. (D) Schematic
representation of various constructs having deletions at 50 and 30 flanking regions for BC200 and Gmo22 transgenic mice.
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ing to protocol (27), which were subsequently transferred into
the oviduct of 0.5-day pseudopregnant, CD-1 foster mice.
DNA tail biopsy and Southern blot analysis
DNA from 3-week-old mouse-tails was extracted as
described (28). Approximately 5 mg of genomic DNA was
digested with PstI or EcoRI, fractionated on 0.8% agarose
gels, and transferred to GeneScreen nylon membranes
(NEN DuPont) by positive pressure blotting. Membranes
were hybridized with a
32P-labeled probe for respective
genes, and washed twice with 0.5· SSPE, 0.5% SDS at
65 C and exposed to MS ﬁlm (Kodak) at  80 C overnight.
RNA blot analysis
Total RNA was extracted from different mouse tissues using
TRIzol reagent (Gibco BRL) according to the manufacturer’s
instructions. RNA was separated on 6% polyacrylamide/7M
urea gels and electro-transferred to positively charged nylon
membranes (Qiagen or Ambion). After ultraviolet (UV)
cross-linking, membranes were hybridized at 58 C overnight
in 1 M sodium phosphate pH 6.2, 7% SDS with
32P-labeled
oligonucleotide probes: for BC200 RNA—BC207: 50-cTTG-
TTGCTTTGAGGGAAGTTACGCTTATTTggtac-30;f o r
G22 RNA—G22-30:5 0-TGTGCCCTGAGCAGAGGGCAG-
TGGCACCGGAGCCCAC-30; and as a control, probe for
7SL RNA was used, 7SL_30:5 0-AAGAGACGGGGTCTC-
GCTATG-30. Nucleotides in lower case are unrelated to the
BC200 sequence. After hybridization, membranes were
washed twice with 1· SSC, 0.1% SDS for 20 min at 58 C
and exposed to MS ﬁlm (Kodak) at  80 C overnight.
DIG-labeled in situ hybridization
Digoxigenin (DIG)-labeled riboprobes for hybridization with
BC200 RNA were generated from plasmid pKK536-6, which
contained 71 nt (position 119–189) from the 30-unique
domain of the human BC200 gene cloned into pBluescript
KS (+) between the KpnI and SacI sites of the MCS. Follow-
ing linearization with either KpnI [antisense (AS)] or SacI
[sense (S)], DIG-labeled RNA probes were in vitro tran-
scribed using T7 or T3 polymerases, respectively, and the
DIG RNA Labeling Kit (Roche Molecular Biochemicals)
according to the manufacturer’s instructions.
DNA templates featuring a T7 promoter followed by the S
and AS sequence for part of G22 RNA (position 205–278)
were generated by PCR ampliﬁcation from pGmo- ( 383)
plasmid using pairs of oligonucleotides: G22antiRev 50-GG-
AGTCTGAGGTTGCAGTGGGC-30 and G22T7antiF 50-TA-
ATACGACTCACTATAGGTCGAGACAGAGTTCCACC-
CTG-30, for AS probe G22sensRev 50-GTCGAGACAGAG-
TTCCACCCTG-30 and G22T7sensF 50-TAATACGACT-
CACTATAGGGAGTCTGAGGTTGCAGTGGGC-30 for
the S probe. G22 RNA probes were in vitro transcribed
from the respective PCR products in the presence of DIG-
modiﬁed UTP according to the manufacturer’s instructions
(Roche Molecular Biochemicals).
BC200 and Gmo22 RNA transgenic mice, 6–10 weeks old,
and their wild-type littermates were transcardially perfused
with 0.1 M phosphate-buffered saline (PBS), pH 7.2 followed
by freshly prepared 4% paraformaldehyde in PBS (PFA). The
brains were removed and postﬁxed overnight at 4 C. The
next morning, 30 mm coronal sections were cut on a vibrating
microtome (Leica) and, for ease of handling, further ﬁxed in
PFA for one week at 4 C. Prior to hybridization, free-ﬂoating
sections were washed 3 · 5 min with PBS, incubated in
Proteinase K (1 mg/ml) for 30 min at 37 C, incubated for
2 · 5 min in freshly prepared glycine (0.1 M) and ﬁnally
rinsed 2 · 15 min in 2· SSC. Prehybridization [50% Forma-
mide, 1.2 M NaCl, 0.02 M Tris (pH 7.5), 2· Denhardts,
2 mM EDTA, 1 mg/ml denatured salmon sperm DNA,
1 mg/ml total yeast RNA and 0.1 mg/ml yeast tRNA] was
at 50 C for 1 h in a humid chamber. Hybridization using
200 ng/ml DIG-labeled RNA probes in prehybridization
buffer plus 10% dextran sulfate was overnight at 50 Ci na
humid chamber. The sections were washed 2 · 5 min with
2· SSC, digested with RNase A (2 mg/ml) for 30 min at
37 C, washed 3 · 15 min with 2· SSC at 50 C and ﬁnally
washed under high stringency 3 · 30 min with 0.1· SSC,
0.1% sodium pyrophosphate. To detect the DIG label, the
sections were washed 3 · 5 min with PBS, blocked
(1% Blocking Reagent, Roche Molecular Biochemicals) for
60 min at RT and incubated overnight at 4 C with sheep
anti-DIG-AP (1:500 in blocking buffer, Roche Molecular
Biochemicals). After washing 4 · 5 min with PBS and equili-
brating 2 · 5 min in 0.1 M NaCl, 0.1 M Tris (pH 9.5), 0.05 M
MgCl2, the antibody was detected enzymatically using nitro
blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate
as a substrate. The sections were ﬁnally washed, mounted,
and coverslipped with VectaMount (Vector Laboratories,
Inc., Burlingame, USA). Hybridization signals were photo-
graphed using a Nikon E600 microscope and Open Lab Soft-
ware (Improvision, Coventry UK).
In situ hybridization of mouse embryos
In situ hybridization on embryonic sections of BC200 trans-
genic mice was performed as described previously (9). On
day E15 or E18 embryos were removed from the uteri of
pregnant mice, washed twice with PBS pH 7.2, ﬁxed in 4%
paraformaldehyde in PBS overnight at 4 C, and equilibrated
in ascending concentrations of sucrose (up to a 20%).
Embryos were embedded with Tissue Tek OCT medium
(SAKURA) and sagittal cryo-sections of 15 mm thickness
were generated. Probes (AS or S) speciﬁc for BC200 RNA
were in vitro transcribed in the presence of [a-
35S]UTP,
from the template pKK536-6 (see above), and linearized
with KpnI or SacI, respectively. Following hybridization
(see above) using 5 · 10
6 c.p.m./ml of
35S-labeled RNA
probe, slides were washed for 30 min at room temperature
in 2· SSC and then digested with 30 mg/ml RNase A at
37 C for 30 min. Subsequently, slides were washed for
60 min with 2· SSC at 50 C and ﬁnally under high stringency
for 3 h at 50 C in 0.1· SSC, 0.05% Na-pyrophosphate and
14 mM 2-mercaptoethanol with gentle stirring. Wash solution
was cooled down to room temperature, and slides were dehy-
drated through 50, 70 and 90% ethanol containing 0.3 M
NH4OAc for 2 min each. Vacuum dried sections were
exposed to X-Omat ﬁlm (Kodak).
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Immunoprecipitation was performed as described previously
(18). Anti-PABP antibody (18) and anti SRP9 antibody (24)
were immobilized on protein G-sepharose beads (Pharmacia)
and washed thrice with IP buffer [12.5 mM HEPES (pH 7.4),
150 mM NaCl, 2 mM MgCl2, 0.25% NP-40 and 5% gly-
cerol]. The beads were incubated with the antibody overnight
at 4 C. The unbound antibody was washed (4 times) with the
IP buffer. The bound beads were subsequently incubated for
2–3 hours with crude brain extracts (S2) from BC200
( 2271) and Gmo22 ( 383) transgenic mice, at 4 C. Follow-
ing incubation, the beads were washed with IP buffer (4–5
times) to remove the unbound sample. RNA was extracted
from the bound complexes using TRIzol reagent (Gibco
BRL). The RNA was analyzed by northern blot analysis
(see above).
T7 in vitro transcription of BC200 RNA and G22 RNA
BC200 and G22 npcRNAs were in vitro transcribed from
DNA templates containing a T7 promoter. DNA template
for in vitro transcription of BC200 RNA was obtained
from pPBC200 plasmid (23) digested with DraI restriction
endonuclease. G22 RNA was transcribed directly from PCR
product ampliﬁed from pGmo- ( 383) plasmid using the
following oligonucleotides: Gmo22T7_F 50-TAATACGAC-
TCACTATAGGCCGGGCGCGGTGGCTCA-30 andGmoTn-
Rev 50- AGGGAAAAATATGAAAAGGGGATTTGGG-30.
Transcription with T7 RNA polymerase was performed in a
reaction volume of 200 ml (29). RNAs were separated on
denaturing 8% polyacrylamide, 7 M urea gels and passively
eluted in 0.3 M NaOAc buffer (pH 5.2), 1 mM EDTA, 0.2%
phenol at 4 C overnight. Subsequently, RNAs were EtOH pre-
cipitated and dissolved in 30 mlH 2O.
Gel shift assay
For binding assays to human PABP, BC200 RNA and G22
RNA were in vitro transcribed from plasmid and PCR tem-
plates (see above) containing a T7 promoter in the presence
of [a-
32P]UTP using 250 U of T7 RNA polymerase followed
by gel puriﬁcation (see above). Before incubation with
recombinant PABP protein, RNAs were heat denatured
(2 min at 85 C) and subsequently cooled in ice. Complex
formation of recombinant PABP with BC200 RNA and
G22 RNA was performed in a reaction volume of 20 ml, con-
taining 10 mM Tris–HCl (pH 7.4), 100 mM KCl, 2.5 mM
MgCl2, 2 mM DTT, 5% glycerol, 0.5% Triton X-100, 2 mg
heparin, 1 mg BSA, 2.5 mg tRNA and 5 U of ribonuclease
inhibitor (RNasin, MBI). Aliquots (0.05 pmol) of RNAs
were incubated with increasing concentrations of PABP as
indicated in Figure legends (Figure 7). Competition assays
were performed under above binding conditions with constant
concentrations of PABP around 25 nM and with increasing
concentrations of competitor RNA (Figure 7). All reactions
were incubated for 30 min at 4 C, followed by 10 min at
room temperature. RNA and RNA–protein complexes were
separated on native 6% (w/v) polyacrylamide gels, containing
1· TBE [90 mM Tris, 64.6 mM boric acid, 2.5 mM EDTA
(pH 8.3)]. Electrophoresis was performed at 20 C in 0.5·
TBE running buffer for 10–12 h. Gels were ﬁxed in 10%
acetic acid, 25% 2-propanol for 30 min at room temperature,
dried by vacuum blotting and exposed to MS ﬁlm (Kodak) at
 80 C overnight.
The apparent K50 values of the RNA–protein complexes
were deﬁned as the protein concentration at which 50% of
the input RNA was shifted to an RNP complex (30).
Native gel electrophoresis
The native complexes from the S2 brain extracts were separ-
ated on a composite gel containing 4% acrylamide/
bisacrylamide (80:1, w/w) and 0.4% (w/v) agarose as descri-
bed (31). Following electrophoresis, the RNPs and RNAs
were electroblotted on Nylon membrane (Ambion). The
RNA was immobilized by UV cross-linking, the membrane
was then hybridized with
32P-labeled BC207 oligonucleotide
probe (see above) complimentary to the unique region of
BC200 RNA. Hybridization and washings were performed
as described (31).
Mouse housing conditions
All lines were established by breeding male and female foun-
ders with C57/Bl6J mice. Non-transgenic siblings were used
as control animals. Mice were bred at the central animal facil-
ity of the University Clinic, Mu ¨nster in a temperature (21 C)
controlled room with 12:12 h light/dark cycle and housed
under non-enriched standard conditions. Pups were weaned
19–23 days after birth and females were kept separately
from males. Mice were housed in standard [27 (l) · 21 (w) ·
15 (h) (cm)] or [42 (l) · 27 (w) · 15 (h) (cm)] cages, for up to
three or seven littermates, respectively.
RESULTS
Flanking promoter elements in the BC200 RNA locus
are responsible for tissue-specific transcription
In order to investigate the transcriptional activity of the
BC200/G22 locus in transgenic mice, we designed various
constructs in which the 50 ﬂanking regions were sequentially
deleted: BC200 ( 2271), BC200 ( 515), Gmo22 ( 383),
BC200 ( 250), Gmo22 (+1) (Figure 1D). In two of the
BC200 constructs, the 30 ﬂanks were also shortened. For
example in BC200 ( 250), 139 nt instead of 772 nt 30 ﬂanks
[as in BC200 ( 2271)] were retained. Finally, in BC200
( 515), the 30 ﬂank was completely removed except for
19 nt that follow the 200 nt corresponding to the BC200
RNA coding region (see Figure 1D). This should address
the possibility whether elements that inﬂuence transcription
are also located downstream of BC200 RNA gene.
When total RNA from different tissues of three independ-
ent BC200 ( 2271) and BC200 ( 515) transgenic mouse
lines was analyzed we observed that the brain-speciﬁc
expression pattern of BC200 RNA (with low expression
level in testis) (Figure 1B and C) is largely reproduced and
comparable to native BC200/G22 activity in Anthropoidea
and Lorisiformes (9,10,32,33). However, one of the trans-
genic mouse lines, BC200 ( 515), showed a low transcrip-
tional activity of BC200 gene in the heart (Figure 1B). The
differences in transcription patterns of the BC200 RNA
gene within BC200 ( 515) transgenic mouse lines most
likely reﬂect the effect of the position of integration in the
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caused by the shorter 50 ﬂanks, which would fortuitously pro-
vide additional enhancer(s) to the 50-ﬂanking region, rather
than being an effect of regulator element(s) deletion located
in the 30-ﬂanking region of the BC200 locus.
It has been shown that upstream sequence elements in the
BC200/G22 locus of Lorisiformes and Anthropoidea contain
conserved external promoter elements similar to RNA poly-
merase II and other pol III genes (10). For example, a con-
served TATA-like motif maps to around position  20 and
 30; a second conserved sequence block, positioned  70 bp
from the insertion point (coinciding with the +1 position of
the transcript) is similar to the proximal sequence element
(PSE-motif). Finally, a distal sequence element (DSE-like
motif) is located  220 bp upstream from the +1 transcrip-
tional start of both npcRNAs (10). Additional elements are
expected to be responsible for tissue-speciﬁc expression.
We decided to test whether shortened ﬂanks are still sufﬁcient
to maintain tissue-speciﬁc transcription of BC200 and G22
transgenes in mice. Two similar constructs were generated,
BC200 ( 250) and Gmo22 ( 383). The construct BC200
( 250) has 250 bp of the upstream sequence from human
and Gmo22 ( 383) has 383 bp from the Galago moholi
locus, presumably involved in regulation of transcription of
BC200 RNA and G22 RNA, respectively (Figure 1D) (10).
From these constructs we generated three independent lines
for BC200 ( 250) and Gmo22 ( 383) transgenic mice.
Northern blot analysis using total RNA extracted from differ-
ent tissues showed that both RNAs were predominantly
expressed in the brain (Figure 1B and C). Once more, we
observed low levels of transcription of the BC200 and G22
transgenes in heart and additionally in kidney. Thus, we con-
ﬁrmed that the predicted regulatory elements located in the
50-ﬂanking region in the BC200 locus are sufﬁcient to main-
tain transcriptional activity of the retroposed elements with
high-expression in the brain, although repression in other
tissues was somewhat diminished.
Next, we generated three independent transgenic mouse
lines with construct Gmo22 (+1), in which the complete 50
ﬂanking G22 RNA sequence was removed (Figure 1D). In
order to analyze these transgenic mice, total RNA from dif-
ferent tissues was extracted and northern blot hybridization
was performed with a G22 RNA-speciﬁc probe. We failed
to detect even a weak signal on our blots indicating that the
G22 dimeric Alu element is transcriptionally inactive in
the transgenic mice. Based on these results, we conﬁrmed
our prediction that regulatory elements upstream of BC200
and G22 RNA sequences in the BC200/G22 locus are
important for their transcription. Importantly, our data
support the notion that in intact organisms external promoter
elements are required for transcriptional activity of SINE
retronuons (10).
BC200 RNA and G22 RNA are localized to dendrites
Anthropoidea BC200 RNA is selectively expressed in the
nervous system (9,33,34). The distribution of human BC200
RNA shows a clear dendritic localization in the brain (9,34).
Using BC200 ( 2271) transgenic mice, we examined
whether the BC200 RNA speciﬁcally expressed in the mouse
brain had a similar subcellular localization pattern as native
BC200 RNA in human brain (9). In situ hybridization on
coronal sections through the hippocampus of BC200
( 2271) transgenic mice using an AS probe designed against
the unique region of BC200 RNA clearly showed that BC200
RNA is expressed in the CA1, CA2 and CA3 pyramidal cells
of the hippocampus (Figure 2A), where RNA is found in the
somatic cytoplasm and in both apical and basal dendrites
(Figure 2B). Dendritic localization is fairly uniform, except
in stratum lucidum of area CA3, the terminal ﬁelds of the
dentate mossy ﬁbers (Figure 2A), as is the case for phylogen-
etically unrelated rodent BC1 RNA. There is little or no
expression in the granular cells of the dentate gyrus
(Figure 2A). In the cortex, BC200 RNA is expressed in all
layers (I–VI), but most prominently in the large pyramidal
cells of layer V (Figure 2C). As in the hippocampus, labeling
in the cortex was evident in both somatic cytoplasm and den-
drites. In amygdala, where the basal lateral area is more
intensely labeled than the central area (Figure 2D), higher
magniﬁcation reveals clear dendritic staining (Figure 2E).
As G22 RNA also is predominantly and speciﬁcally
expressed in the brain (Figure 1C), we examined whether
G22 RNA exhibits a dendritic localization pattern in the cor-
responding transgenic mice similar to BC200 RNA. Indeed,
G22 RNA was somatodendritically localized (see Figure 3A
and C). While in the hippocampus of BC200 ( 2271) trans-
genic mice there is intense dendritic staining in stratum radia-
tum of the CA1 and CA2 regions, in Gmo22 ( 383)
transgenes, not all cells are stained in the CA1 and CA2
region, however, the dendrites in the stratum radiatum of
CA1 and CA2 region show substantial labeling, albeit,
weaker in comparison to BC200 RNA. This might simply
be due to differences in expression levels of G22 RNA and
BC200 RNA in the investigated transgenic mice. Unlike
BC200 transgenes, where there are variable levels of BC200
RNA in the cells of the different cortical layers, in Gmo22
transgenes, the RNA shows a uniform distribution in all
layers. Presumably, due to the weaker expression levels of
G22 RNA there is no clear dendritic signal observed in the
cortical neurons. Apart from exhibiting common dendritic
localization patterns, BC200 RNA and G22 RNA have differ-
ent expression patterns in other areas of the brain. For
example, while BC200 RNA is expressed at very low levels,
if at all, in the dentate gyrus, G22 RNA is expressed at high
levels in dentate gyrus, evident by the intense staining in the
somata as well as the corresponding dendritic ﬁeld of dentate
gyrus (Figure 3A and C, higher magniﬁcation not shown).
Control S probe in each case did not show any speciﬁc
labeling (Figure 3A–D). Furthermore, sections of wild-type
mouse brains were used as an additional control in
hybridizations with both AS and S probes for both BC200
and G22 RNA. As expected, there is no speciﬁc labeling
with either S or AS probe (Figure 3D). In order to compare
the signal in dendrites, the non-dendritic tubulin mRNA
was included as a negative control (Figure 3E). We observed
an intense signal in the cell bodies but clearly no signal in
dendritic ﬁelds.
Prenatal expression of BC200 RNA in transgenic mice
As there are indications that BC1 RNA is expressed prena-
tally in the developing nervous system (35), and switched
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(36), we examined expression of BC200 RNA in embryos
of transgenic mice. On embryonic day 15, labeling was
weak and possibly, like BC1 RNA (37), also detectable in
non-neuronal cells. A later embryonic stage (E18) showed
prominent expression in the brain, spinal cord and in a differ-
ent plane in the retina (Figure 4).
The transgenic BC200 RNP has similar mobility
as native BC200 RNP
In order to determine whether BC200 RNA in transgenic
mice forms an RNP similar to the native BC200 RNP, we
performed native gel electrophoresis with crude cytoplasmic
extracts (S2) prepared from human brain and transgenic
mouse brain as described (18); in vitro transcribed RNA
was also loaded as a control. The RNPs and the RNA were
transferred onto nylon membrane and hybridized with
32P-
labeled oligonucleotide BC207, complementary to the
unique region of BC200 RNA. RNP from BC200 transgenic
mice, BC200 ( 2271), and the native BC200 RNP from
human brain migrate with similar mobilities, indicating
that they have comparable sizes and in all likelihood similar
protein components (Figure 5). In either case, free RNA
could not be detected in the crude extracts (Figure 5).
Next, we checked whether the protein partners of BC200
RNP in the transgenic mice are identical to those of the
native BC200 RNP in order to validate the mouse model
for further functional studies.
BC200 RNA and G22 RNA bind common protein
partners, SRP9/14 and PABP
Recently, it was shown that PABP and SRP9/14 proteins
were part of the BC200 RNP complex in the human brain
(18,24). Moreover, it has been reported that Alu RNAs
have a potential to interact with the heterodimer SRP9/14
protein (23,38). In order to investigate whether the BC200
RNA and G22 RNA had corresponding protein partners in
the respective transgenic mice, immunoprecipitations were
carried out against PABP and heterodimer SRP9/14 proteins
using anti-PABP (18) and anti-SRP9 (24) antibodies, res-
pectively. Crude S2 brain extracts were prepared from
BC200 ( 2271) and Gmo22 ( 383) transgenic mice as
reported previously (18). Both npcRNAs were efﬁciently
immunoprecipitated with the antibodies mentioned above
but not with pre-immune sera (Figure 6A and B). This con-
ﬁrms that the BC200 RNP complex formed in BC200
( 2271) transgenic mice brain is similar to that of native
BC200 RNP in the human brain containing at least PABP
and the protein heterodimer SRP9/14, and that the mouse
model can be used for further studies. Moreover, the G22
RNP formed in Gmo22 ( 383) transgenic mice has at least
three common protein partners with human BC200 RNA,
indicating that the two RNPs are similar and therefore
could be involved in related functions in the brain.
In vitro binding studies of BC200 RNA and
G22 RNA with PABP
To further study similarities or differences of the primate
BC200 RNA and G22 RNA with respect to their interaction
with PABP, we investigated in detail the binding properties
of both npcRNAs.
First, we tested the ability of PABP to interact selectively
and speciﬁcally with BC200 RNA. We examined whether
selective binding between recombinant PABP and in vitro
transcribed BC200 RNA could be detected by gel retardation
assays in the presence of vast excess of non-speciﬁc yeast
tRNA (molar ratio 1:2000). Consistent with previous reports
(18), we were able to detect two distinct complexes in our
assay that might correlate with two potential PABP binding
sites in the 41 nt long A-rich region of BC200 RNA
(Figure 7B). The BC200 RNA–PABP complex was formed
with an apparent K50 value of 16 nM. We also performed
competition assays with unlabeled BC200 RNA as a compe-
titor (see Materials and Methods) (Figure 7D). The intensity
of the upper shifted band was completely abolished with a 16-
fold excess of unlabeled BC200 RNA, and with 80-fold
excess, both bands were mostly competed (Figure 7D).
We next tested whether in vitro transcribed G22 RNA
would interact with human recombinant PABP in the pres-
ence of a vast excess of non-speciﬁc yeast tRNA (see
above). When increasing amounts of PABP were added to
Figure 2. In situ hybridization of transgenic BC200 RNA. (A) In the
hippocampus there is robust labeling in the cell bodies and dendrites of the
hippocampus proper. (B) An enlargement of hippocampal area CA1 shows
clear labeling in stratum radiatum containing the apical dendrites of the
pyramidal cells. (C) In the cortex overlying the hippocampus, corresponding
to primary somatosensory cortex, BC200 RNA is present in most cells in all
the layers; however, dendritic localization is particularly evident in the large
pyramidal cells of layer V. (D) Amygdala, BC200 RNA is unevenly
distributed in the various nuclei of the amygdala. The basal lateral amygdala
is more strongly labeled than is the central amygdala. (E) Dendrites in the
basal lateral amygdala are clearly stained. Abbr. BLA, basal lateral amygdala;
CA, central amygdala; DG, dentate gyrus; gc, granule cells; ml, molecular
layer; pc, pyramidal cells; sl, stratum lucidum; so, stratum oriens; sr, stratum
radiatum; WM, white matter; I–VI, cortical layers.
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RNP complex as we did with the BC200/PABP RNP. The
G22–PABP RNP complex was formed with an apparent
K50 value of 12 nM (Figure 7A). In experiments where
32P-labeled G22 RNA was competed from the G22/PABP
RNP with unlabeled G22 RNA, we observed similar
results as with the BC200 RNA complex (Figure 7C and
D). Thus, we demonstrated speciﬁcity of the G22 RNA–
PABP interaction. To gain further insight into the interaction
between the investigated RNAs and PABP, we performed
competition experiments, whereby
32P-labeled G22 RNA
and BC200 RNA were competed from their RNPs with
unlabeled BC200 RNA and G22 RNA, respectively
(Figure 7E and F).
Figure 3. In situ hybridization of transgenic BC200 and G22 RNA. (A) Dendritic localization of Gmo22 RNA, substantial labeling was observed in the CA1,
CA2 and CA3 regions of the hippocampus. At higher magnification of cells in the CA1 region, labeling is evident up to the distal ends of the dendrites. In the
dentate gyrus (DG), labeling in the dendritic field was more intense than in the CA1-CA3 dendritic fields. The control, with S probe did not show any labeling.
(B) There is no significant labeling observed for G22 RNA in Gmo +1 transgenic animals with either the AS probe or the contol (S) probe. The higher
magnification further confirms that there is no specific labeling. (C) Dendritic localization of BC200 RNA, intense signal was observed in the CA1, CA2 and
CA3 areas of the hippocampus and in some of the cortical layers (Figure 2). The stratum lucidum does not show any labeling. The higher magnification reveals
strong labeling in the cell bodies as well as the dendritic field of CA1. The dentate gyrus shows very low signal if at all in comparison to other areas of the brain.
The control (S) probe does not show any labeling. (D) In situ hybridization experiments with (AS) probes for both BC200 RNA and G22 RNA on the sections of
wild-type (WT) mice, as a control, did not show any significant labeling as evident at both lower and higher magnifications. (E) In situ hybridization showing the
localization of tubulin mRNA. There is intense labeling in all the regions of hippocampus, CA1, CA2 and CA3, and also the cells in the dentate gyrus. In the
cortex, the cells in almost all the layers are stained intensely. The signal is distinctly confined to the somatic region in all the cells that are labeled. The higher
magnification further shows that the dendritic field in the hippocampus is devoid of any labeling.
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in its central part, G22 RNA contains two A-rich regions of
15 nt each, in the center and near the 30 end. When
32P-labeled
G22 RNA was competed with unlabeled BC200 RNA for
binding with PABP, we observed reduced intensity of the
upper shifted band with 5- to 80-fold excess of competitor
(Figure 7E). At similar conditions
32P-labeled BC200 RNA
was competed with unlabeled G22 RNA. The reduction in
the intensities of the shifted bands was observed with 3- to
160-fold excess of unlabeled G22 RNA (Figure 7F).
The slight differences observed in competition might be
due to co-operative binding of two PABP molecules to the
longer A-rich region of BC200 RNA in comparison to indi-
vidual binding of monomers to the two separated binding
sites in G22 RNA. Our results clearly demonstrate that both
BC200 and G22 npcRNAs form speciﬁc RNP complexes
with PABP. Thus, it is tempting to speculate that the G22
RNP in Lorisiformes brain might be involved in functions
similar to its analog, the anthropoid BC200 RNP, e.g. possi-
bly in the regulation of dendritic translation (20–22).
DISCUSSION
Usually, novel genes arise by duplication of existing ones.
There are two major modes of duplication: (i) a segment
containing an entire gene (usually several, and up to hundreds
or thousands of kilobases, occasionally even entire chromo-
somes or genomes) duplicate or (ii) an RNA transcript of a
gene is converted into cDNA by the action of the enzyme
reverse transcriptase and inserted at random positions of the
genome. The latter requires fortuitous juxtaposition to promo-
ter elements and, as a result, leads with lower frequency to
functional gene products that can be exapted into variant
and, over time, novel functions (11). The unsuccessful events
are prevalent in genomes of multicellular species and are
known as retropseudogenes, SINEs and the like. Multiple
retroposon targeting of the same locus is rare as there are
potentially more than a hundred thousand potential integra-
tion sites. If it occurs, the precise integration at a given loca-
tion is less surprising due to the consensus sequence 50-TT/
AAAA-30 of preferred integration sites. In the case presented
here, it is quite unusual that both transcripts have been
conserved in their respective lineages for at least 35 million
years. This is a strong indication for recruitment (exaptation)
into a function resulting in purifying selection. Nevertheless,
the respective genes are relatively young and establishing
their functions is not trivial, especially when they occur in
species that are not amenable to experimentation due to
conservational or ethical reasons. One way to circumvent
these limitations is the generation of transgenic animals
that express the genes to be studied. Their expression
patterns may provide the ﬁrst leads concerning their function.
Figure 4. BC200 RNA expression in mouse embryos. (A) E15 embryos,
sagittal middle sections, S control. (B) E15 embryos, sagittal central sections
through the spinal cord; AS probe. (C) E18 embryos, sagittal lateral sections
through the retina; AS probe. The BC200 signal is seen in brain and retina.
(D) E18 embryos, sagittal central sections through the spinal cord; AS probe.
The BC200 signal is seen in brain, spinal cord and retina.
Figure 5. Comparison of human and transgenic mouse BC200 RNPs. S2
extracts from both human and transgenic mouse brains were separated on a
native gel and the resulting blot was hybridized with
32P-labeled
oligonucleotide (BC207) complimentary to the unique region of the human
BC200 RNA gene. The first lane contains in vitro transcribed BC200 RNA.
Figure 6. Immunoprecipitation of BC200 and G22 RNPs from transgenic
mouse brain. (A and B) Samples of the S2 fractions from BC200 ( 2271) and
Gmo22 ( 383) transgenic mouse brains (same amount in each case) were
immunoprecipitated with antibodies against PABP and SRP9 proteins. RNA
was extracted from the precipitated complexes and separated on 7 M urea/8%
polyacrylamide gels, and the resulting transfer blots were hybridized as
described (see Materials and Methods). As a control in each case, RNA from
complexes immunoprecipitated from the crude extract using pre-immune
serum (PABP and SRP9) was loaded. In vitro transcribed BC200 RNA and
G22 RNA were loaded as an additional control (first lane in each case).
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complexed protein partners provides clues to their functions.
We generated at least three founder lines for each construct
in order to exclude atypical expression patterns due to contri-
butions of the genomic integration loci. While tissue-speciﬁc
expression patterns were identical in founder lines that were
generated from the same transgene, we could observe differ-
ences in their distribution regarding cell-types, (such as cor-
tical neurons; data not shown). This could be ascribed to
slight differences in expression of the respective constructs
when integrated in different chromosomal loci. This is
more pronounced when less ﬂanking regions are present.
These shorter ﬂanks (mainly 50) might have lost regulatory
sequences or simply provide less buffering against inﬂuences
from the loci of integration. For example, BC200 RNA with
2271 nt of 50 ﬂanking sequences revealed signals on northern
blot only in brain and at a reduced level in the testis
(Figure 1A). Even in the presence of only 515 nt upstream,
expression was mostly restricted to these organs
(Figure 1B, left panel). In contrast, when only 250 nt were
upstream of BC200 RNA or 383 nt upstream of G22 RNA,
we observed, in addition to expression in the brain, noticeable
signals in heart and kidney, but not in liver and spleen
(Figure 1B, right panel, Figure 1C, left panel). Expression
levels of the  515 BC200 RNA construct indicate that, if
any, at most 19 nt at the 30 ﬂank are necessary for tissue-
speciﬁc expression. Apart from the internal box-A and
box-B RNA polymerase III promoter elements, which are
probably necessary for basal transcription levels (10), the
regulatory elements for efﬁcient, cell-type-speciﬁc and devel-
opmentally regulated expression of BC200 and G22 RNAs
must reside within 515 nt upstream from the transcriptional
start and, if at all, 19 nt downstream of the transcriptional
termination.
Our results indicate that the region upstream of the BC200
RNA gene ( 515– 250) might be involved in repressing
expression in tissues other than brain and testes. More likely,
ﬂanking regions simply protect from position effects.
In line with earlier cell transfection experiments (10),
wherein removal of the entire 50 ﬂanking sequences resulted
in a sequence with intact internal box-A and box-B RNA
polymerase III promoter elements and 147 nt 30 ﬂanking
sequences (Figure 1D), expression of the dimeric Alu
element-derived G22 RNA was completely abolished
(Figure 1C, right panel). This is convincing proof that these
elements are not sufﬁcient for transcription in vivo, at least
under normal conditions.
Moreover, our data indicate that the Alu-derived retropo-
sons harboring intact internal promoter elements are ‘dead
on arrival’ (39), unless they are fortuitously furnished by
Figure 7. Interaction of human PABP with BC200 RNA and G22 RNA detected by gel retardation analysis. (A and B) Interaction of human PABP with G22
RNA and BC200 RNA, respectively.
32P-labeled RNAs were incubated with human recombinant PABP protein as follows: free RNA, no protein was added;
lanes 1–12: 1, 2, 3, 4, 6, 8, 12, 16, 25, 32, 50 and 62 nM PABP was added; in (B) lanes 13 and 14 represent increasing concentrations of PABP up to 100 and
125 nM, respectively. RNP complex formation between (C)
32P-labeled G22 RNA and PABP; (D)
32P-labeled BC200 RNA and PABP, in the presence of
unlabeled G22 RNA and BC200 RNA, respectively for (C and D). (E) Competition assay between
32P-labeled G22 RNA and PABP, in the presence of unlabeled
BC200 RNA. (F) Competition assay between
32P-labeled BC200 RNA and PABP, in the presence of unlabeled G22 RNA. Lanes indicated as follows: free RNA,
no protein or competitor RNA was added; contr. RNP, initial RNP complex formed in the presence of 25 nM of PABP, no competitor RNA was added; (C–E)
lanes 1–7: 2, 10, 20, 40, 80, 150 and 200 nM competitor RNA was added to the initial RNP complex; lanes 8 for (C and D), represent the same conditions as
lanes 7, except that no PABP protein was added in reactions. (F) Lanes 1–11: 2, 4, 8, 17, 35, 70, 140, 200, 280, 400 and 560 nM G22 RNA was added to the
initial RNP complex.
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ingly rare.
Expression of BC200 RNA in transgenic mice revealed
cell-type-speciﬁc expression that generally is analogous to
the pattern observed in human brain sections (Figure 2)
and to the rodent analogue BC1 RNA. Similarly, the trans-
genic BC200 RNA is upregulated during embryonic develop-
ment of the nervous system (Figure 4). Early embryonic
expression appears to be reduced but more promiscuous
with respect to tissue or cell-types. Importantly, as in
primates, BC200 RNA was transported to dendrites
(Figure 3). Congruence of BC200 RNA and G22 RNA trans-
gene expression is not too surprising due to the high-level of
sequence similarity. A surprising divergence between all
BC200 RNA and G22 RNA transgenes is the extreme differ-
ence (absence and high-level expression) of the respective
RNAs in dentate gyrus.
Several hundred mRNAs are estimated to be dendritic.
Consistently, non-protein coding RNAs that play a role in
synthesis or regulatory aspects of translation can be found
in dendrites. Examples for the former are rRNA (40,41)
and tRNAs (42), for the latter moderate levels of SRP RNA
(36), high-levels of BC1 and BC200 RNA and most recently
even a micro RNA [miR-134; (43)]. Because of the great
similarity of G22 RNA, especially to BC200 RNA
(basically, G22 is a dimer of BC200 RNA), it is not surpri-
sing that G22 RNA is transported into dendrites. More
work in transgenic models is needed to delineate the struc-
tures and/or motifs that are responsible for dendritic locali-
zation (44).
Both BC RNAs and miR-134 are possibly involved in the
regulation of translation (20–22,43,45). Deletion of BC1
RNA leads to a behavioral phenotype (see above) and miR-
134 is thought to control translation of the synaptic Limk1
protein, thereby regulating the size of dendritic spines. It
would not be surprising if G22 RNA had a function in a pro-
simian branch that closely corresponds to that of BC200 RNA
in anthropoid primates. Observations reported here support
the assumption that G22 RNA shares PABP as a major pro-
tein partner with BC1 RNA and BC200 RNA and the SRP
protein dimer SRP9/14 with BC200 RNA. The observation
that the K50 values of interaction of PABP with BC200
and G22 RNAs are slightly different (Figure 7), might be
due to the distribution of the A-rich sequences on both
RNAs. A rather long stretch (41 nt) is located in the
center of BC200 RNA, while G22 RNA features two shorter
A-rich regions (15 nt each) between the monomers and 30 to
the right monomer.
Of the dendritic small npcRNAs, the best-studied is
BC1 RNA in rodents. Although it is not ancestrally related
to the primate dendritic npcRNAs characterized in this
paper, it might be a functional analogue due to a similar
tripartite domain structure (a 50 domain with similarity to
a SINE, a central A-rich domain, and a 30 unique non-
repetitive domain) and, as mentioned above, shared protein
binding partners. It will be interesting to test whether mice
transgenic for BC200 RNA or G22 RNA, when crossed
into BC1 RNA-deleted mice, will exhibit compensation
of the reduced exploratory behavior and increased anxiety
of KO mice.
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